Described are cyclohexylamine derivatives of Formula (I), Formula (II) or Formula (III) and their pharmaceutically acceptable salts thereof. The compounds are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease. The substituents are described in the specification.
1
描述了公式(I)、公式(II)或公式(III)的
环己胺衍
生物及其药学上可接受的盐。这些化合物是N
MDA受体通道复合物的拮抗剂,可用于治疗脑血管疾病,例如脑缺血、心脏骤停、中风和帕
金森病。取代基在说明书中有描述。